Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04471051 · ClinicalTrials.gov registry record
An Observational Cohort Trial of Outcomes and Antibody Responses Following Treatment With COVID19 Convalescent Plasma in Hospitalized COVID-19 Patients
A clinical trial, sponsored by University of Colorado, Denver.
- Completed
- Registry status
- 255
- Enrollment target
NCT04471051 is a clinical trial that has completed, run by University of Colorado, Denver. The registered enrollment target is 255 participants.
The verdict
NCT04471051 has completed, sponsored by University of Colorado, Denver.
- COMPLETED
- Registry status
- 255 participants
- Enrollment target
Study Summary
This is an observational study designed to learn more about how COVID19 convalescent plasma works in patients with COVID19 compared to those patients who did not receive convalescent plasma treatment. Information about patient recovery will be collected from participants' electronic medical records to evaluate safety, clinical outcomes, and SARS-CoV2 antibody responses in patients who were treated with convalescent plasma under a separate expanded access protocol, NCT04372368.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 255 participants |
| Start Date | 2020-04-30 |
| Est. Completion | 2020-08-20 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04471051
The ClinicalTrials.gov registry entry for NCT04471051 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 255 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Colorado, Denver, which has 1,283 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT04471051 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04471051 about?
NCT04471051 is a clinical study titled "An Observational Cohort Trial of Outcomes and Antibody Responses Following Treatment With COVID19 Convalescent Plasma in Hospitalized COVID-19 Patients". This is an observational study designed to learn more about how COVID19 convalescent plasma works in patients with COVID19 compared to those patients who did not receive convalescent plasma treatment. Information about patient recovery will be collected from participants' electronic medical records ...
What is the current status of trial NCT04471051?
This trial is currently completed. The enrollment target is 255 participants. The study started on 2020-04-30. Estimated completion is 2020-08-20.
Who is sponsoring clinical trial NCT04471051?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.